Clinical Trial Update: Hypofractionated Radiotherapy for Nonmelanoma Skin Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating hypofractionated radiotherapy for Non-melanoma skin cancer has been terminated. Sponsor: Barretos Cancer Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-melanoma Skin Cancer

Snippet

Sponsor: Barretos Cancer Hospital | Conditions: Non-melanoma Skin Cancer | Phase 2 | Status: TERMINATED